Legal Opinion
Boehringer Ingelheim International GmbH v. Barr Laboratories, Inc.
Court of Appeals for the Federal Circuit
Decided May 7, 2010No. 09-1032oPublished
1Opinion of the Court
ORDER
2Per curiam
Defendant-Appellee Mylan Pharmaceuticals Inc. filed a combined petition for panel rehearing and rehearing en banc. The panel requested a response from Plaintiffs-Appellants Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharmaceuticals, Inc. The court granted Apotex, Inc. and Apotex Corp. leave to file a brief amici curiae in support of Defendant-Appellee’s petition.
The petition for rehearing was considered by the panel that heard the appeal, and thereafter the petition for rehearing en banc, the response to the petition, and amici curiae brief were referred to the…
Also in this document: Dissent.
3Cases cited7 opinions
- Pfizer, Inc. v. Teva Pharmaceuticals USA, Inc.Court of Appeals for the Federal Circuit · 2008
- Gerber Garment Technology, Inc. v. Lectra Systems, Inc. And Lectra Systems, S.A.Court of Appeals for the Federal Circuit · 1990
- Applied Materials, Inc. v. Advanced Semiconductor Materials America, Inc.Court of Appeals for the Federal Circuit · 1996
- Boehringer Ingelheim International GmbH v. Barr Laboratories, Inc.Court of Appeals for the Federal Circuit · 2010
- Studiengesellschaft Kohle Mbh, as Trustee for the Max-Planck-Institut Fur Kohlenforschung v. Northern Petrochemical CompanyCourt of Appeals for the Federal Circuit · 1986
2 more not listed; retrieve them via the Exa API.